Paul J Nederkoorn Selected Research

2,6-dinitrotoluene (DNT)

1/2022	Impact of the lockdown on acute stroke treatments during the first surge of the COVID-19 outbreak in the Netherlands.
11/2019	Determinants of extended door-to-needle time in acute ischemic stroke and its influence on in-hospital mortality: results of a nationwide Dutch clinical audit.
4/2016	Association between i.v. thrombolysis volume and door-to-needle times in acute ischemic stroke.
1/2016	Thrombolysis in Stroke within 30 Minutes: Results of the Acute Brain Care Intervention Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul J Nederkoorn Research Topics

Disease

48	Stroke (Strokes) 01/2022 - 09/2009
21	Ischemic Stroke 12/2021 - 01/2011
17	Carotid Stenosis (Carotid Artery Stenosis) 01/2021 - 09/2003
16	Infections 01/2022 - 09/2009
8	Pathologic Constriction (Stenosis) 01/2021 - 08/2002
7	Hemorrhage 01/2022 - 09/2015
5	Pneumonia (Pneumonitis) 01/2022 - 01/2018
5	Cerebral Hemorrhage 01/2019 - 11/2010
4	Infarction (Infarctions) 01/2020 - 01/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 02/2015
3	Lacunar Stroke 03/2014 - 01/2011
2	Deglutition Disorders (Dysphagia) 01/2022 - 12/2021
2	Atherosclerotic Plaque (Atheroma) 01/2021 - 08/2018
2	Hyperhomocysteinemia 03/2014 - 06/2011
2	Cerebral Small Vessel Diseases 06/2011 - 01/2011
1	Leukocytosis (Pleocytosis) 10/2022
1	Hemorrhagic Stroke 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021
1	Vascular Remodeling 01/2021
1	Amaurosis Fugax 09/2020
1	Wounds and Injuries (Trauma) 06/2019
1	Fibromuscular Dysplasia 06/2019
1	Atrial Fibrillation 06/2018
1	Anaphylaxis (Anaphylactic Shock) 01/2018
1	Exanthema (Rash) 01/2018
1	Intracranial Hypertension 09/2017
1	Hyperglycemia 04/2017
1	Brain Ischemia (Cerebral Ischemia) 01/2017
1	deficiency of adenosine deaminase 2 05/2016
1	Kidney Diseases (Kidney Disease) 03/2014
1	Leukoencephalopathies 02/2014
1	Carotid Artery Diseases 02/2013
1	Brain Injuries (Brain Injury) 01/2012
1	Atherosclerosis 06/2011

Drug/Important Bio-Agent (IBA)

23	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 09/2009
8	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2021 - 04/2011
4	2,6-dinitrotoluene (DNT)IBA 01/2022 - 01/2016
4	LipidsIBA 01/2022 - 01/2021
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2019
2	Phenobarbital (Luminal)FDA Link 01/2021 - 08/2017
2	Biocompatible Materials (Biomaterials)IBA 01/2020 - 01/2015
2	Vitamin K FDA Link 01/2018 - 09/2015
2	AnticoagulantsIBA 12/2017 - 09/2015
2	HomocysteineIBA 03/2014 - 06/2011
2	CalciumIBA 02/2013 - 09/2012
2	Contrast MediaIBA 01/2011 - 09/2003
1	C-Reactive ProteinIBA 10/2022
1	AntigensIBA 01/2022
1	Biological ProductsIBA 01/2021
1	16S Ribosomal RNAIBA 01/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Lipoprotein(a)IBA 01/2021
1	trimethylamineIBA 01/2021
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 09/2020
1	Glucose (Dextrose)FDA LinkGeneric 11/2019
1	Nitroglycerin (Dynamite)FDA LinkGeneric 06/2019
1	AminoglycosidesIBA 01/2019
1	Carbapenems (Carbapenem Antibiotics)IBA 01/2019
1	Penicillins (Penicillin)FDA Link 01/2019
1	Cephalosporins (Cephalosporin Antibiotics)IBA 01/2019
1	MacrolidesIBA 01/2019
1	Monobactams (Monobactam Antibiotics)IBA 01/2019
1	diazobenzenesulfonic acid (DASA)IBA 12/2018
1	Immunologic Factors (Immunomodulators)IBA 12/2018
1	Thrombin FDA Link 08/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2018
1	DiureticsIBA 07/2018
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 07/2018
1	Acetaminophen (Paracetamol)FDA LinkGeneric 06/2018
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 12/2017
1	Blood Glucose (Blood Sugar)IBA 04/2017
1	Anesthetics (Anesthetic Agents)IBA 08/2016
1	Adenosine (Adenocard)FDA LinkGeneric 05/2016
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 12/2015
1	N(4)-oleylcytosine arabinosideIBA 09/2015
1	Third Generation CephalosporinsIBA 04/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015

Therapy/Procedure

23	Therapeutics 01/2022 - 08/2009
9	Endarterectomy (Thromboendarterectomy) 11/2019 - 03/2010
5	Stents 11/2019 - 07/2009
5	Carotid Endarterectomy 10/2019 - 08/2002
4	Thrombectomy 12/2021 - 01/2011
4	Length of Stay 01/2018 - 10/2014
2	Decompressive Craniectomy 01/2020 - 09/2017
2	Aftercare (After-Treatment) 11/2019 - 01/2017
2	Surgical Decompression 08/2015 - 02/2015
1	Immunomodulation 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Contraindications 11/2019
1	Cutaneous Administration 06/2019
1	Transdermal Patch 06/2019
1	Musculoskeletal Manipulations (Manipulative Therapy) 06/2019
1	Patient Discharge 06/2018
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2016
1	ABC protocol 01/2016
1	Long-Term Care 01/2012